Kyowa Kirin Co., Ltd.
https://www.kyowakirin.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Kyowa Kirin Co., Ltd.
Antiretroviral Pregnancy Registry Lights Way For Pregnancy Postmarketing Studies
The 30+ year-old program, which monitors prenatal exposure to 164 drugs, should be the template for other efforts, US FDA officials say, because disease-based pregnancy registries ‘have a better track record.’
Endo Launches First US Mitigare Generic Following Micro Labs Lawsuit
Endo’s Par has moved on the first FDA-approved generic version of Hikma’s Mitigare prevention of gout flares – weeks after another ANDA sponsor, Micro Labs, sought to clear its own path to market via a lawsuit.
Deals Abound At Advanz
Advanz has acquired exclusive rights to register and commercialize a Phase III candidate from Dimerix in multiple territories, alongside agreements with Kyowa Kirin, Bayer and GP Pharm.
Gene Therapy Cost Effectiveness: US ICER Supports Million-Dollar Prices
Institute for Clinical and Economic Review continues to assign high values to novel gene therapies, suggesting that Orchard’s pending ‘arsa-cel’ for MLD could be cost effective at a price as high as $4 million per treatment.
Company Information
- Industry
- Biotechnology
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
Pharmaceuticals
- Nutraceuticals
- Radiopharmaceuticals, Contrast Agents
-
Biotechnology
- Drug Discovery Tools
- Other Names / Subsidiaries
-
- Archimedes Pharma Ltd.
- Centus Biotherapeutics Ltd.
- Daiichi Fine Chemical Co., Ltd.
- Fujifilm Kyowa Kirin Biologics Co., Ltd.
- Kirin Pharma Company, Limited
- Kyowa Kirin Asia Pacific Pte. Ltd.
- Kyowa Kirin Australia Pty Ltd
- Kyowa Kirin International PLC
- Kyowa Pharma Chemical Co., Ltd.
- ProStrakan Group plc
- Kyowa Kirin
- Kyowa Kirin Frontier Co., Ltd.
- Kyowa Hakko Kirin (Singapore) Pte. Ltd.
- Kyowa Hakko Kirin Co., Ltd.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice